Clinical Data:

• BlueStar Diabetes has been supported by robust clinical data, including clinical trials and real-world evidence.
• Studies have shown improvements in glycemic control, reduction in HbA1c levels, and increased patient engagement with the use of BlueStar.

Mechanism:

• BlueStar is a mobile app and web platform that supports individuals with Type 1 and Type 2 diabetes, offering personalized coaching, data integration with health devices, and insights.
• It includes features like SmartVisit™ reports for sharing data with care teams and a Care Management Portal for population health management and monitoring health trends.

Safety and Side Effects:

• BlueStar is contraindicated for individuals under 18, pregnant individuals, and those using a continuous glucose monitor.

Patient Eligibility:

• Suitable for a wide range of patients, including those on oral medications, insulin therapy, or a combination of both.

Cost:

• Free to download on App Store (Apple) and Google Play Store (Android)

‍